Perioperative morbidity and mortality in octogenarians sustaining traumatic osteoporotic type 4 and 5 thoracolumbar and lumbar fractures: a retrospective study with 3 years follow-up - Top-Institutions - MDSpire

Perioperative morbidity and mortality in octogenarians sustaining traumatic osteoporotic type 4 and 5 thoracolumbar and lumbar fractures: a retrospective study with 3 years follow-up

  • By

  • Pavlina Lenga

  • Gelo Gülec

  • Karl Kiening

  • Andreas W. Unterberg

  • Basem Ishak

  • April 13, 2023

  • 0 min

Share

Top Institutions in Surgery

Brief introduction explaining scope and methodology.

  • #1

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Orthopedic Surgery
    • Neurosurgery
    • Geriatrics
    • Spine Surgery

  • #2

    Johns Hopkins Hospital
    Johns Hopkins Hospital

    Baltimore, MD

    Key Differentiators

    • Neurosurgery
    • Orthopedic Surgery
    • Geriatrics
    • Trauma Surgery

  • #3

    Hospital for Special Surgery (HSS)
    Hospital for Special Surgery (HSS)

    New York, NY

    Key Differentiators

    • Orthopedic Surgery
    • Spine Surgery
    • Geriatrics

  • #4

    Charité – Universitätsmedizin Berlin
    Charité – Universitätsmedizin Berlin

    Berlin, Berlin

    Key Differentiators

    • Orthopedic Surgery
    • Neurosurgery
    • Geriatrics
    • Trauma Surgery

  • #5

    University of California, San Francisco (UCSF) Medical Center
    University of California, San Francisco (UCSF) Medical Center

    San Francisco, CA

    Key Differentiators

    • Orthopedic Surgery
    • Neurosurgery
    • Geriatrics

Original Source(s)

Perioperative morbidity and mortality in octogenarians sustaining traumatic osteoporotic type 4 and 5 thoracolumbar and lumbar fractures: a retrospective study with 3 years follow-up

  • by Pavlina Lenga, Gelo Gülec, Karl Kiening, Andreas W. Unterberg, Basem Ishak

  • April 13, 2023

Related Content

What happens to conservatively managed chronic subdural haematoma

Prevalence and symptoms of incidental meningiomas: a population-based study

FDA Approves New Option in Obesity

The Allurion Gastric Balloon System is now authorized by the US Food and Drug Administration for short-term weight loss in adults aged 22 to 65 years with obesity and a body mass index of 30 to 40 kg/m2.